Moreover, Runx1 also has been implicated in various malignancies associated with CAF abundance, including breast, bladder, cervical, and rectal cancer,[33, 42] suggesting its potential involvement in other cancer types by accelerating the pathogenic MMT process for CAF formation. This evidence concerns the gene RUNX1 and rectal cancer.